Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy

Journal of Urology

Volumn 189, Issue 1 SUPPL, 2013, Pages

  Nam, Robert K ^a,d   Saskin, Refik ^c   Lee, Yuna ^c   Liu, Ying ^c   Law, Calvin ^b,d   Klotz, Laurence H ^a   Loblaw, D Andrew ^b   Trachtenberg, John ^c   Stanimirovic, Aleksandra ^a   Simor, Andrew E ^b   Seth, Arun ^b   Urbach, David R ^c,d   Narod, Steven A ^d  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b Sunnybrook Health Sciences Centre   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

adverse effects; biopsy; mass screening; prostatic neoplasms

Indexed keywords

ADULT; AGED; ARTICLE; CANADA; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; ICD-10; ICD-9; INTERNAL VALIDITY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROBABILITY; PROSTATE BIOPSY; PROSTATE CANCER; REPEAT PROCEDURE; TRANSRECTAL ULTRASONOGRAPHY; TRANSRECTAL ULTRASOUND GUIDED PROSTATE BIOPSY; URINARY TRACT DISEASE; URINARY TRACT HEMORRHAGE; URINARY TRACT INFECTION; URINARY TRACT OBSTRUCTION;

EID: 84870900967     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2012.11.015     Document Type: Article

References (17)

1. K.K. Hodge, J.E. McNeal, T.A. Stamey Ultrasound guided transrectal core biopsies of the palpably abnormal prostate J Urol 142 1989 66
2. M.K. Terris Ultrasonography and biopsy of the prostate P.C. Walsh, A.B. Retik, E.D. Vaughan, 8th ed. Campbell's Urology vol. 4 2002 Saunders Philadelphia 3038 3054
3. D.A. Kapoor, I.W. Klimberg, G.H. Malek Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy Urology 52 1998 552
4. M. Aron, T.P. Rajeev, N.P. Gupta Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study BJU Int 85 2000 682
5. K.R. Ghani, D. Dundas, U. Patel Bleeding after transrectal ultrasonography-guided prostate biopsy: a study of 7-day morbidity after a six-, eight- and 12-core biopsy protocol BJU Int 94 2004 1014
6. P.R. Sieber, F.M. Rommel, C.G. Theodoran Contemporary prostate biopsy complication rates in community-based urology practice Urology 70 2007 498
7. J. Feliciano, E. Teper, M. Ferrandino The incidence of fluoroquinolone resistant infections after prostate biopsy-are fluoroquinolones still effective prophylaxis? J Urol 179 2008 952
8. R. Raaijmakers, W.J. Kirkels, M.J. Roobol Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program Urology 60 2002 826
9. R.A. Deyo, D.C. Cherkin, M.A. Ciol Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases J Clin Epidemiol 45 1992 613
10. G. Lee, K. Attar, M. Laniado Trans-rectal ultrasound guided biopsy of the prostate: nationwide diversity in practice and training in the United Kingdom Int Urol Nephrol 39 2007 185
11. S.S. Jeon, S.H. Woo, J.H. Hyun Bisacodyl rectal preparation can decrease infectious complications of transrectal ultrasound-guided prostate biopsy Urology 62 2003 461
12. K.B. Laupland, T. Ross, J.D. Pitout Community-onset urinary tract infections: a population-based assessment Infection 35 2007 150
13. A. de la Taille, P. Antiphon, L. Salomon Prospective evaluation of a 21-sample needle biopsy procedure designed to improve the prostate cancer detection rate Urology 61 2003 1181
14. J.C. Presti Jr, J.J. Chang, V. Bhargava The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial J Urol 163 2000 163
15. C.G. Roehrborn, J.G. Nuckolls, J.T. Wei The benign prostatic hyperplasia registry and patient survey: study design, methods and patient baseline characteristics BJU Int 100 2007 813
16. G. Giannarini, A. Mogorovich, F. Valent Continuing or discontinuing low-dose aspirin before transrectal prostate biopsy: results of a prospective randomized trial Urology 70 2007 501
17. C.B. Begg, E.R. Riedel, P.B. Bach Variations in morbidity after radical prostatectomy N Engl J Med 346 2002 1138